Skip to main content
SpringerLink
Log in

Revolution dawning in cardiotoxicity testing

  • News and Analysis
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

Stem cell technology and computational modelling offer the promise of reducing the current burden of cardiotoxicity assessment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: The HERG channel and proarrhthymia.
Authors
  1. Kelly Rae Chi
    View author publications

    You can also search for this author in PubMed Google Scholar

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chi, K. Revolution dawning in cardiotoxicity testing. Nat Rev Drug Discov 12, 565–567 (2013). https://doi.org/10.1038/nrd4083

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4083

  • Springer Nature Limited

This article is cited by

Search

Navigation